|
|
|
Insider
Information: |
Alam John J |
Relationship: |
CEO & President, Direc... |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
866,331 |
|
Indirect Shares
|
737,179 |
|
|
Direct
Value |
$65,884,842 |
|
|
Indirect Value
|
$2,596,204 |
|
|
Total
Shares |
1,603,510 |
|
|
Total
Value |
$68,481,046 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Med. Dev. Group &... |
2008-10-01 |
136,792 |
2008-10-01 |
5,140 |
Premium* |
|
Cervomed Ord Shs |
CRVO |
CEO & President, Direc... |
2023-11-09 |
729,539 |
2023-11-09 |
732,039 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2007-08-06 |
4 |
AS |
$35.00 |
$1,075,200 |
D/D |
(30,720) |
119,324 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2007-05-07 |
4 |
AS |
$30.59 |
$994,175 |
D/D |
(32,500) |
102,960 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2007-08-06 |
4 |
OE |
$9.07 |
$350,801 |
D/D |
30,720 |
150,044 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-10-11 |
4 |
AS |
$35.35 |
$265,125 |
D/D |
(7,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-08-30 |
4 |
AS |
$35.00 |
$262,500 |
D/D |
(7,500) |
103,856 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2007-05-07 |
4 |
OE |
$10.19 |
$199,984 |
D/D |
16,364 |
119,324 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-20 |
4 |
AS |
$27.40 |
$182,302 |
D/D |
(6,612) |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-27 |
4 |
AS |
$27.02 |
$178,656 |
D/D |
(6,612) |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-10 |
4 |
AS |
$26.23 |
$173,485 |
D/D |
(6,614) |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-03 |
4 |
AS |
$25.86 |
$170,986 |
D/D |
(6,612) |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
|
2005-12-14 |
4 |
S |
$27.40 |
$143,406 |
D/D |
(5,220) |
88,714 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-10-01 |
4 |
AS |
$32.65 |
$138,860 |
D/D |
(4,253) |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-08-30 |
4 |
OE |
$18.47 |
$138,525 |
D/D |
7,500 |
111,356 |
|
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-10-11 |
4 |
OE |
$18.47 |
$138,525 |
D/D |
7,500 |
111,356 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-06-19 |
4 |
OE |
$15.60 |
$130,486 |
D/D |
8,281 |
136,792 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-01 |
4 |
AS |
$40.33 |
$120,990 |
D/D |
(3,000) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-15 |
4 |
AS |
$43.55 |
$96,440 |
D/D |
(2,207) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-12-13 |
4 |
AS |
$38.54 |
$76,458 |
D/D |
(1,980) |
101,876 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-12-13 |
4/A |
AS |
$38.54 |
$76,458 |
D/D |
(1,980) |
103,376 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-10 |
4 |
OE |
$10.19 |
$67,397 |
D/D |
6,614 |
143,406 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-20 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-08-27 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2008-09-03 |
4 |
OE |
$10.19 |
$67,376 |
D/D |
6,612 |
143,404 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Medicines Dev. & CMO |
|
2006-12-06 |
4 |
AS |
$44.69 |
$67,035 |
D/D |
(1,500) |
103,856 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Med. Dev. Group & CMO |
|
2006-11-22 |
4 |
AS |
$44.36 |
$66,540 |
D/D |
(1,500) |
104,563 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|